Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kuopio University Hospital
The study will include 30 relapse-remitting multiple sclerosis patients. Assessments of heart rate variability and myocardial ventricular repolarisation pattern will be done 1) before fingolimod, 2) first day of fingolimod 3) after 3 months use and 4) after 12 months use of fingolimod.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18 - 65 years
Understands the proposed research and actions to be taken
The written informed consent has given
clinical indication to fingolimod-treatment
You may not be if
Patient refuses
Patient takes or has taken part in other clinical drug trial during the last month
No clinical indication to the use of fingolimod
Contraindication to the use of fingolimod
Clareo Health | Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple Sclerosis
